Jyong BiotechMENS
13F holders, Q4 2025 (December 31)19holders +11
12new positions
2sold out
1famous investor
$3.95avg. 13F price*
At the end of Q4 2025, 19 institutions reported holding Jyong Biotech Ltd. (MENS) in their 13F filings, up 11 from Q3 2025. 12 opened new positions and 2 sold out. The largest holders were BlackRock, Inc. ($1.0M), UBS Group AG ($575K) and Jane Street Group, LLC ($275K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Jyong Biotech Ltd.
- CUSIP
- G83116106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $1.6M |
| Exits | 2 | $1.3M |
All 13F filers, Q3 2025 → Q4 2025: 619,369 shares bought and 33,858 shares sold, net +585,511 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| BlackRock, Inc. | 0.00% | New | 260,823 | $1.0M |
| UBS Group AG | 0.00% | Add +27022.5% | 145,648 | $575K |
| Jane Street Group, LLC | 0.00% | New | 69,560 | $275K |
| Geode Capital Management, LLC | 0.00% | Add +19.6% | 64,382 | $254K |
| Millennium Management | 0.00% | Add +209.4% | 40,258 | $159K |
| Morgan Stanley | 0.00% | Add +879.2% | 28,113 | $111K |
| Bank of America Corp. | 0.00% | New | 23,182 | $92K |
| Man Group plc | 0.00% | New | 14,222 | $56K |
| China Universal Asset Management Co., Ltd. | 0.00% | New | 12,389 | $49K |
| Citigroup Inc. | 0.00% | New | 10,896 | $43K |
| JPMorgan Chase & Co. | 0.00% | New | 6,051 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +18303.8% | 4,785 | $19K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | New | 3,694 | $15K |
| Barclays PLC | 0.00% | New | 3,540 | $14K |
| GF Fund Management Co. LTD. | 0.00% | New | 1,493 | $6K |
| BNP Paribas Financial Markets | 0.00% | Reduce -23.4% | 1,300 | $5K |
| Osaic Holdings, Inc. | 0.00% | New | 420 | $2K |
| Farther Finance Advisors, LLC | 0.00% | New | 204 | $806 |
| Cornerstone Financial Management LLC | 0.00% | — | 14 | $55 |
"% of holder's portfolio" is MENS's weight in each manager's 13F, not the share of Jyong Biotech Ltd. the manager owns.